A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-11-14
Summary
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Conditions
- Idiopathic Short Stature
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 2 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-08
- Primary Completion
- 2040-12-31
- Completion
- 2040-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
NCT06212947 ·Status: RECRUITING
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED
-
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT00458263 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690 ·Status: RECRUITING
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
NCT06927310 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia
NCT02055157 ·Status: COMPLETED ·Phase: PHASE2
-
Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients
NCT05858606 ·Status: RECRUITING ·Phase: NA
-
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
NCT01009905 ·Status: COMPLETED
-
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
NCT01970800 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
NCT00191165 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
NCT03794609 ·Status: TERMINATED
-
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
NCT07073014 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
NCT03255694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
NCT05829252 ·Status: COMPLETED
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513 ·Status: RECRUITING ·Phase: PHASE3